Combination therapy with long-acting beta-agonists plus inhaled corticosteroids is no more effective than LABA monotherapy for mortality outcomes and severe exacerbations in moderate to very severe COPD and is associated with serious adverse effects.
peter.frith@health.sa.gov.au
Peter Anthony
PA
Frith